Results 131 to 140 of about 1,312,400 (160)
Some of the next articles are maybe not open access.

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Nature Reviews Clinical Oncology, 2021
D. Doroshow   +9 more
semanticscholar   +1 more source

Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2019
Over the last decade, the treatment of patients with advanced non-small cell lung cancer (NSCLC) has become reliant on tissue and/or blood biomarkers to help guide treatment decisions.
N. Pennell   +3 more
semanticscholar   +1 more source

Biomarkers in Earthworms

2000
Earthworms are believed to be so-called key species within ecosystems and are often exposed to a wide range of anthropogenic compounds released to the terrestrial environment. As a consequence, they may suffer from the toxicity of these compounds. For these and other reasons, earthworms have been used extensively in ecotoxicological studies.
Scott-Fordsmand, J. J., Weeks, J. M.
openaire   +3 more sources

Biomarkers in pediatrics: Children as biomarker orphans

PROTEOMICS – Clinical Applications, 2010
AbstractBiomarkers have enormous potential to improve patient care by establishing tests of diagnosis, prognosis, and treatment effects. Successfully translating a biomarker from discovery to clinical application demands high‐quality discovery research and high‐quality clinical studies for biomarker validation; however, there are additional challenges ...
Allen D. Everett, William J. Savage
openaire   +3 more sources

Biomarkers in melanoma

Scandinavian Journal of Clinical and Laboratory Investigation, 2016
Malignant melanoma remains the skin cancer with the highest number of mortalities worldwide. While early diagnosis and complete surgical excision remain the best possibility for curing disease, prognosis at the stage of metastasis is still poor. Recent years have brought about considerable advances in terms of understanding the pathogenesis of melanoma
openaire   +3 more sources

Biomarkers of Frailty

Molecular Aspects of Medicine
Several biomarkers have been proposed to identify frailty, a multisystemic age-related syndrome. However, the complex pathophysiology and the absence of a consensus on a comprehensive and universal definition make it challenging to pinpoint a singular biomarker or set of biomarkers that conclusively characterize frailty.
Mariam, El Assar   +3 more
openaire   +2 more sources

Biomarkers

Molecular Aspects of Medicine, 2002
Griffiths, Helen R   +17 more
openaire   +2 more sources

The Biomarker Guide

, 2004
K. Peters, C. Walters, J. Moldowan
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy